SunJour Healthcare News: Golden Biotechnology Corporation Will Change Cancer Treatment in the Near Future

It is currently impossible to immediately cure any type of cancer. Chemotherapy drugs such as Taxol and Gemcitabine are highly effective in killing cancer cells, but because of their drug resistance and strong side effects, they can only be used for short-term treatment. This is the basis for the first line of medication. Drugs for targeted therapy can be used to treat specific tumors, but they still produce drug resistance. There is no anti-cancer drug on the market that can treat respiratory diseases and metabolic syndromes at the same time, so the current treatments against lung cancer have all failed in the end. It is also important to maintain the efficacy of the respiratory system and treat metabolic syndromes. This issue is also of concern for the US FDA. 

Cancer patients who have many diseases are common worldwide. Therefore, it is extremely important that the drug used to fight cancer has a broad spectrum so that the patient has a chance to recover. Finding a basic drug that not only has the effect of inhibiting cancer but also has no side effects is the most urgent goal at present.

Golden Biotechnology Antroquinonol®

A. [Concurrent therapy]:

Maximize the therapeutic effect of chemotherapy drugs. After 4 to 8 cycles, drug resistance disappeared. Supporting the immune system and uninterrupted treatment allowed chemotherapy to achieve the desired results of continuous treatment.

B. [Intermittent treatment]:

Only use Antroquinonol® for therapy when the patient cannot tolerate chemo and when time permits, the patient can re-attempt chemo. Antroquinonol® can be used as an add-on adjuvant therapy.

Purpose:

1. Maintaining the patient's quality of life (QoL) without the need to interrupt chemotherapy or develop resistance and deterioration.

2. Chemotherapy intervention is conducive to short-term results of the poisoning of solid tumors.

3. Maintaining results and repairing damage to organ function, such as liver, kidney and cardiovascular inflammation so that damage and inflammation can be alleviated.

Antroquinonol® will surely become “the standard of the SOC (standard of care).”